The Mexico clinical nutrition market was valued at USD 782.33 Million in 2025 and is expected to grow at a CAGR of 4.80%, reaching USD 1250.27 Million by 2035. The market growth is driven by increasing awareness of malnutrition and chronic disease management, along with a growing elderly population requiring specialized nutritional support. Expansion of hospital and home healthcare services, rising adoption of enteral and parenteral nutrition, and advancements in fortified and medical nutrition products are expected to contribute significantly to market growth in the forecast period.
Base Year
Historical Period
Forecast Period
According to Manuel Alejandro Martínez-Vázquez et al., 2025, the increasing prevalence of Crohn’s disease, affecting 9,953 patients, and ulcerative colitis, affecting 33,060 patients in Mexico, is driving demand for specialized clinical nutrition, boosting market growth.
The rising prevalence of malnutrition, increasing chronic diseases, and growing awareness of clinical nutrition benefits are driving demand, significantly boosting the market growth across hospitals, clinics, and home care settings.
The key players in the market are expanding product portfolios, enhancing distribution networks, and investing in innovative formulations, which strengthens market competitiveness and accessibility, further accelerating the growth of the clinical nutrition market in Mexico.
Compound Annual Growth Rate
4.8%
Value in USD Million
2026-2035
*this image is indicative*
Clinical nutrition plays a crucial role in supporting patient health, recovery, and overall well-being by providing tailored dietary solutions for various medical conditions. It involves specialized nutritional interventions, including enteral and parenteral nutrition, to manage illnesses, enhance recovery, and prevent complications. The market is anticipated to grow at a 4.80% in the forecast period of 2026-2035, driven by the rising prevalence of chronic diseases, increasing hospitalizations, and growing awareness of therapeutic nutrition. Key segments include oral nutrition supplements, tube feeding, and total parenteral nutrition, with hospitals, clinics, and home care settings being primary end users. Market expansion is supported by technological advancements and a focus on patient-centric healthcare solutions.
Rising Diabetes Burden to Accelerate Significant Market Demand
The escalating prevalence of diabetes, which continues to increase the demand for specialized nutritional support a key growth driver in the market. According to 2024 data, Mexico reports a 16.4% diabetes prevalence among its adult population, with more than 13.5 million diagnosed cases. The International Diabetes Federation noted in 2024 that the SACA region, including Mexico, is projected to experience a rise in diabetes cases from 35 million to 52 million by 2050. This growing disease burden is expected to significantly strengthen the need for clinical nutrition solutions, supporting sustained market growth.
Some of the notable trends in the market include an increasing emphasis on evidence-based pediatric nutrition and a growing focus on community-driven nutrition initiatives.
Growing Focus on Evidence-Based Pediatric Nutrition Is Likely to Elevate the Market Expansion
The market is witnessing a rising focus on evidence-based pediatric nutrition, driven by expanding professional education initiatives. In March 2025, FrieslandCampina Institute launched its Mexico chapter through an online symposium in Mexico City, highlighting new tools and strategies in pediatric nutritional education. This initiative aims to strengthen knowledge sharing, offer continuous learning programs, and provide access to global research and best practices for healthcare professionals. Such developments are reinforcing clinical expertise and shaping more advanced nutritional care approaches, thereby supporting sustained market growth in the coming years.
Rising Community-Centric Nutrition Initiatives To Boost the Mexico Clinical Nutrition Market Value
The increasing focus on community-driven malnutrition prevention programs reflects a broader shift toward early detection and education-based interventions is a key market trend. This shift aligns with global innovation, such as the June 2023 initiative by Abbott in collaboration with Real Madrid and the Real Madrid Foundation to expand malnutrition awareness and screening. The effort highlighted the importance of accessible screening tools, community training, and nutrition education. Such influential partnerships are inspiring similar initiatives in Mexico, ultimately supporting wider clinical nutrition adoption and driving sustained market growth.
Market Breakup by Type
Market Breakup by Application
Market Breakup by Form
Market Breakup by End User
Market Breakup by Distribution Channel
Cancer Expected to Lead the Market Share by Application
The application segment includes cancer, malnutrition, metabolic disorders, gastrointestinal diseases, neurological diseases, and other conditions. Among these, cancer is expected to lead due to its rising prevalence and the growing need for specialized nutrition to support treatment tolerance, immunity, and overall patient recovery. A key driver is the escalating burden of oncology cases, supported by the OECD’s May 2023 report, which highlighted cancer as the fourth leading cause of mortality and responsible for 1 in 14 premature deaths, with an estimated 46,200 premature annual deaths projected between 2023 and 2050. These factors reinforce the increasing reliance on therapeutic nutrition solutions to improve patient outcomes.
The key features of the market report comprise strategic initiatives by the leading players. The major companies in the market are as follows:
Abbott is a leading global healthcare company with a strong presence in the clinical nutrition market, offering evidence-based nutritional solutions that support patient recovery and overall health. The company provides a wide range of clinical nutrition products and maintains an extensive library of clinical resources to assist healthcare professionals with education and product guidance. Abbott remains actively involved in advancing clinical nutrition through product support, expert resources, and continuous engagement with clinicians to enhance patient care across diverse healthcare settings.
Fresenius Kabi is a global leader in clinical nutrition, offering comprehensive enteral and parenteral nutrition solutions that support patients with cancer, digestive disorders, chronic kidney disease, and other serious conditions. Its portfolio includes the Fresubin® range of oral and tube-feeding products, as well as advanced parenteral nutrition systems designed for hospital and home care. Through continuous research, award-winning innovation, and collaboration with medical nutrition associations, the company strengthens its involvement in the clinical nutrition market by addressing malnutrition and improving patient recovery outcomes.
Baxter AG is a long-standing leader in parenteral nutrition, offering advanced intravenous nutrition solutions that address disease-related malnutrition in hospital and home settings. Its next-generation PN formulations are designed to support neonatology, pediatrics, oncology, intensive care, nephrology, and intestinal failure. Baxter remains actively involved in the market by promoting early malnutrition diagnosis, supporting professional development programs, and delivering safe, patient-centric nutrition therapies that improve clinical outcomes.
Danone SE, through its specialized nutrition division Nutricia, plays a significant role in the market. Nutricia develops medical nutrition products for all age groups, focusing on food for special medical purposes used in therapeutic areas such as malnutrition-related diseases, cancer, stroke, epilepsy, congenital metabolic disorders, cystic fibrosis, and growth retardation. The company continually advances nutritional solutions to address evolving therapy needs and supports patients throughout their treatment journeys. Danone’s strong portfolio and commitment to medical nutrition reinforce its presence in the clinical nutrition landscape.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are Nestlé S.A., B. Braun SE, Perrigo Company, and Reckitt Benckiser Group.
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by Form |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share